TOP PAGE
ENGLISH
JAPANESE
|
CONNECT WITH US:
Home
About
Services
Contact
Log in
*
Home
Press release
Aug 05, 2020 11:13 JST
Source:
Mitsubishi Corporation
Mitsubishi Corporation: R&D on Use of CO2 in Concrete
TOKYO, Aug 05, 2020 - (JCN Newswire) - Mitsubishi Corporation is pleased to announce that its proposal for researching and developing new ways to use CO2 in the production of concrete has been selected for the NEDO grant project that encompasses technological developments in the areas of carbon-recycling.
R and D Areas
R&D on Use of CO2 in Concrete
Mitsubishi Corporation (MC) is pleased to announce that its proposal for researching and developing new ways to use CO2 in the production of concrete has been selected for the NEDO1 grant project that encompasses technological developments in the areas of carbon-recycling.
Carbon-recycling technologies make effective use of CO2 emissions captured from steel mills, power plants, cement manufacturing plants, and other facilities to create value-added products. They are being developed as a means to help address climate change. Having recognized their potential, MC is working on those that inject CO2 into concrete, where it becomes mineralized and permanently embedded. Concrete is an essential material for civil engineering and construction projects, and its global market is growing.
Most of the current carbon-recycling technologies are mainly used for a limited scope of unreinforced concrete, such as concrete blocks, so the challenge now is to enhance their mineralization capabilities and broaden their applications.
This joint endeavor between MC, Kajima Corporation, and Chugoku Electric Power Co.,Inc. aims to improve these technologies so that they can also be applied to the reinforced and cast-in-place concretes used in building construction.
MC has already been involved in the development of concrete projects that take advantage of carbon-recycling, including a zero-emission, ecological concrete called CO2-SUICOM2.
CCUS3 technology including Carbon-recycling is an excellent opportunity for MC to leverage its strengths, as collaborations are essential across industries that both emit and use CO2. By developing such businesses, MC will realize its vision of simultaneously generating economic, societal, and environmental value.
Please refer to the attached document for details:
https://bit.ly/39WzyAO
Source: Mitsubishi Corporation
Sectors: Engineering
Copyright ©2025 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.
Related Press Release
Strategic Partnership and Investment with Eagers Automotive Ltd., Including Investment in Unique Independent Used Car Business Across Australia and New Zealand
October 01 2025 20:26 JST
Definitive agreement to implement a joint mine plan between Los Bronces and Andina copper mines
September 17 2025 17:57 JST
Mitsubishi Corporation Invests in Commonwealth Fusion Systems, a US Fusion Energy Start-up from MIT
September 02 2025 11:50 JST
Result of the Business Plan Review for the Offshore Wind Power Generation Projects in Japan
August 27 2025 21:27 JST
Mitsubishi Corporation Invests in Fullerton Health
August 26 2025 11:54 JST
Mitsubishi Corporation to acquire shares in Copper World copper mine project in the US
August 14 2025 11:05 JST
First Shipment of LNG from the LNG Canada Project
July 01 2025 10:00 JST
Mitsubishi Corporation to Invest and Enter into a Business Partnership with DEScycle Ltd., a UK Company Developing Innovative Metal Recycling Technology
June 02 2025 13:35 JST
Mitsubishi Corporation Establishes New Corporate Venture Capital Company
May 30 2025 17:36 JST
Mitsubishi Corporation makes DennoKotsu an equity-method affiliate company, strengthening efforts to address regional transportation challenges
April 11 2025 09:39 JST
More Press release >>
Latest Press Release
The 26th Hong Kong Forum marks successful completion
Dec 03, 2025 22:44 JST
Anime Tokyo Station: Celebrating the 25th Anniversaries of Two Popular Anime with an Anniversary Joint Exhibition Starting November 15
Dec 03, 2025 11:30 JST
Eisai Presents New Data on Anti-Tau Antibody Etalanetug (E2814) at CTAD 2025
Dec 03, 2025 00:01 JST
NEC Launches AI Agent Service in Japan to Automate Procurement Negotiations Using AI
Dec 02, 2025 23:43 JST
Fujitsu develops new technology to support human-robot collaboration
Dec 02, 2025 23:26 JST
Fujitsu establishes international consortium to tackle disinformation/misinformation and new AI risks
Dec 02, 2025 22:55 JST
Fujitsu achieves high-precision, long-duration molecular dynamics simulation for all-solid-state battery interphases with over 100,000 atoms
Dec 01, 2025 23:04 JST
Fujitsu develops multi-AI agent collaboration technology to optimize supply chains, launches joint trials
Dec 01, 2025 22:43 JST
Fujitsu launches 'Fujitsu Accelerator Program for SPORTS' to create new value through Sports x Technology
Dec 01, 2025 22:14 JST
Eisai Submits New Drug Application for Subcutaneous Formulation of "LEQEMBI(R)" for the Treatment of Early Alzheimer's Disease in Japan
Nov 28, 2025 23:00 JST
JFCR, NEC, and Taiho to Develop Cancer Vaccines Utilizing Whole-Genome Information
Nov 28, 2025 19:41 JST
MHI Publishes "MHI REPORT 2025" and "SUSTAINABILITY DATABOOK 2025"
Nov 28, 2025 19:05 JST
Sharp Wins IAM's "Asia IP Elite 2025", Awarded to Companies with Outstanding Intellectual Property Strategy for The Second Consecutive Year
Nov 28, 2025 18:36 JST
Fujitsu builds platform for NSK to create environmental value throughout the product lifecycle of bearing products
Nov 28, 2025 18:01 JST
Fujitsu launches Japan Edition of SAP Fioneer Cloud for Insurance, a next-generation platform supporting core business operations in the Japanese insurance industry
Nov 28, 2025 17:28 JST
NEC Launches Sales Support Solution Utilizing Agentic AI
Nov 27, 2025 22:31 JST
Fujitsu and Yamaguchi University develop low-power edge computing technology for near real-time image processing on small satellites
Nov 27, 2025 22:00 JST
World's first ever spiral escalator renewal project conducted at a commercial facility in Mexico
Nov 27, 2025 11:00 JST
Eisai Completes Rolling Submission to US FDA for LEQEMBI(R) IQLIK(TM) (lecanemabirmb) Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer's Disease Under Fast Track Status
Nov 26, 2025 19:42 JST
Fujitsu accelerates blue carbon certification with ocean digital twin technology
Nov 26, 2025 19:05 JST
More Latest Release >>